Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2025 | 11-2024 | 11-2023 | 11-2022 | 11-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 267 | 166 | 2 | 32 | 813 |
| Receivables | 134 | 52 | 36 | 24 | 42 |
| Inventories | 49 | 67 | 10 | 10 | 10 |
| TOTAL | $596 | $359 | $89 | $157 | $887 |
| Non-Current Assets | |||||
| PPE Net | 2,495 | 2,226 | 2,061 | 1,924 | 1,665 |
| Other Non-Current Assets | 14 | 14 | 14 | 14 | 14 |
| TOTAL | $2,509 | $2,240 | $2,075 | $1,938 | $1,679 |
| Total Assets | $3,105 | $2,598 | $2,164 | $2,095 | $2,567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 591 | 585 |
| Other current liabilities | N/A | 167 | N/A | N/A | 0 |
| TOTAL | $1,813 | $2,094 | $674 | $591 | $621 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40 | 40 | 40 | 26 | 26 |
| Deferred Revenues | 97 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 14 | 14 | 14 | 14 |
| TOTAL | $40 | $54 | $54 | $40 | $40 |
| Total Liabilities | $1,853 | $2,148 | $728 | $631 | $661 |
| Shareholders' Equity | |||||
| Common Shares | 12,642 | 9,139 | 8,690 | 7,552 | 6,273 |
| Retained earnings | -14,368 | -10,835 | -9,128 | -7,728 | -5,974 |
| Other shareholders' equity | 21 | 21 | 12 | 0 | 0 |
| TOTAL | $1,252 | $450 | $1,436 | $1,465 | $1,906 |
| Total Liabilities And Equity | $3,105 | $2,598 | $2,164 | $2,095 | $2,567 |